- UHRA Home
- University of Hertfordshire
- Browsing University of Hertfordshire by Author
Browsing University of Hertfordshire by Author "Chilcot, Joseph"
Now showing items 21-31 of 31
-
Impact of COVID-19 on Patient Experience of Kidney Care: A Rapid Review
Mackintosh, Lucy; Ormandy, Paula; Busby, Amanda; Hawkins, Janine; Klare, Ranjit; Silver, Christina; Da Silva-Gane, Maria; Santhakumaran, Shalini; Bristow, Paul; Sharma, Shivani; Wellsted, David; Chilcot, Joseph; Sridharan, Sivakumar; Steinkamp, Retha; Harris, Tess; Muirhead, Susan; Lush, Vicky; Afuwape, Sarah; Farrington, Kenneth (2023-12-20)Background In March 2020 a pandemic state was declared due to SARS-COV-2 (COVID-19). Patients with kidney disease, especially those on replacement therapies, proved more susceptible to severe infection. This rapid literature ... -
Impact of the COVID-19 pandemic on Services for Patients with Chronic Kidney Disease: Findings of a National Survey of UK Kidney Centres
Mackintosh, Lucy; Busby, Amanda; Farrington, Kenneth; Hawkins, Janine; Afuwape, Sarah; Bristow, Paul; Da Silva-Gane, Maria; Hall, Natalie; Harris, Tess; Hudson, Joanna; Norton, Sam; Ormandy, Paula; Pearce, Christina J.; Santhakumaran, Shalini; Sharma, Shivani; Sridharan, Sivakumar; Steenkamp, Retha; Slevin, Julie; Wellsted, David; Chilcot, Joseph (2023-12-04)Background Services for patients with kidney disease underwent radical adaptations in response to the COVID-19 pandemic. We undertook an online national survey of UK kidney centres to understand the nature, range, and ... -
The importance of illness perception in end-stage renal disease : Associations with psychosocial and clinical outcomes
Chilcot, Joseph (2012-02)Illness perceptions refer to organized beliefs surrounding the symptoms, consequences, time course, controllability, and causes of an illness. Illness perceptions have been shown to predict a range of psychosocial and ... -
Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients
Wileman, Vari; Farrington, Ken; Wellsted, D.; Almond, Mike; Davenport, Andrew; Chilcot, Joseph (2015-09)OBJECTIVES: Patients with end-stage kidney disease receiving haemodialysis (HD) are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate. We studied the association between medication ... -
Negative and positive illness representations of rheumatoid arthritis : a latent profile analysis
Norton, Sam; Hughes, Lyndsay D.; Chilcot, Joseph; Sacker, Amanda; van Os, Sandra; Young, Adam; Done, D.J. (2014-06)This study extends previous work to consider whether individuals with rheumatoid arthritis (RA) can be categorised into groups with similar illness representations. Data from 227 RA patients attending outpatient clinics ... -
Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores
Davenport, Andrew; Guirguis, Ayman; Almond, Michael; Day, Clara; Chilcot, Joseph; Da Silva Gane, Maria; Fineberg, Naomi; Friedl, Karin; Spencer, Benjamin; Wellsted, David; Farrington, Ken (2018-07-01)Introduction: Most patients take time to recover after a hemodialysis (HD) session. It has been suggested that recovery time is associated with intradialytic hypotension and rapid solute clearances. Other studies have ... -
Self-reported antidepressant use in haemodialysis patients is associated with increased mortality independent of concurrent depression severity
Chilcot, Joseph; Farrington, Ken (2020-12-01) -
Self-reported depression symptoms in haemodialysis patients: Bi-factor structures of two common measures and their association with clinical factors
Farrington, Kenneth; Chilcot, Joseph; Almond, Michael; Guirguis, ayman; Friedli, karin; Day, Clara; Davenport, Andrew; Wellsted, David (2018-09)Objective: To validate the factor structure of two common self-report depression tools in a large sample of haemodialysis (HD) patients and to examine their demographic and clinical correlates, including urine output, ... -
Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis : A Randomized, Controlled Feasibility Trial
Friedli, Karin; Guirguis, Ayman; Almond, Michael; Day, Clara; Chilcot, Joseph; Da Silva-Gane, Maria; Davenport, Andrew; Fineberg, Naomi A; Spencer, Benjamin; Wellsted, David; Farrington, Ken (2017-02-07)BACKGROUND AND OBJECTIVES: Depression is common in patients on hemodialysis, but data on the benefits and risks of antidepressants in this setting are limited. We conducted a multicenter, randomized, double-blind, ... -
Social cognitive predictors of intention to test for vCJD in those affected by haemophilia and other clotting disorders
Rowland, Gemma; Robinson, Georgina; Chilcot, Joseph; Troop, Nicholas (2014-06-01)Individuals with bleeding disorders are at increased risk of variant Creutzfeldt-Jakob disease. This study explored social cognitive predictors of screening intentions. Ninety men and women with bleeding disorders, recruited ... -
A study of sertraline in dialysis (ASSertID) : a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis
Friedli, Karin; Almond, Michael; Day, Clara; Chilcot, Joseph; Gane, Maria da Silva; Davenport, Andrew; Guirguis, Ayman; Fineberg, Naomi; Spencer, Benjamin; Wellsted, D.; Farrington, Ken (2015-10-26)BACKGROUND: The prevalence of depression in people receiving haemodialysis is high with estimates varying between 20 and 40 %. There is little research on the effectiveness of antidepressants in dialysis patients with the ...